These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1914775)

  • 1. Oral contraceptive-induced esophageal ulcer. Two cases and literature review.
    Oren R; Fich A
    Dig Dis Sci; 1991 Oct; 36(10):1489-90. PubMed ID: 1914775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary complications of oral contraceptives.
    Lindberg MC
    J Gen Intern Med; 1992; 7(2):199-209. PubMed ID: 1336797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and focal nodular hyperplasia of the liver.
    Hagay ZJ; Leiberman RJ; Katz M; Witznitzer A
    Arch Gynecol Obstet; 1988; 243(4):231-4. PubMed ID: 3223780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein thrombosis associated with prolonged ingestion of oral contraceptive steroids.
    Chu G; Farrell GC
    J Gastroenterol Hepatol; 1993; 8(4):390-3. PubMed ID: 8374097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of oral contraceptive use.
    Williams RS
    Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine and oral contraceptives.
    Mousa GY
    Am J Optom Physiol Opt; 1982 Oct; 59(10):821-3. PubMed ID: 7148975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic effects of smoking and oral contraceptive use.
    Fruzzetti F
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S369-74. PubMed ID: 10368523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tumor in long-term user of oral contraceptives.
    Ferrara BE; Rutland ED
    Postgrad Med; 1988 Nov; 84(6):107-9. PubMed ID: 2847128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual impact of contraception.
    Stubblefield PG
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1513-22. PubMed ID: 8178900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
    Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.